PLATELETS
CHARACTERISTICS OF PLATELETS
• Platelets are DISC shaped.
• Platelets are formed in bone marrow by FRAGMENTATION of
MEGAKARYOCYTES.
• Normal plasma concentration - 150,000 to 300,000 / microlitre.
• Half life - 8-12 days.
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS ACTIN ,
MYOSIN ,
THROMBOSTHENIN
(contractile proteins)
contract platelets
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS Residuals of
GOLGI BODIES
AND
ENDOPLASMIC RETINACULUM
synthesis enzymes and store Ca2+
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS MITOCHONDRIA AND ENZYMES
ATP and ADP production
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS Enzymes for PROSTAGLANDIN
synthesis
prostaglandin is local hormone.
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS FIBRIN STABILIZING PROTEINS
CHARACTERISTICS OF
PLATELETS
CYTOPLASM CONTAINS GROWTH FACTORS
FOR
vascular endothelial cells
vascular smooth muscles
fibroblasts
CHARACTERISTICS OF
PLATELETS
CELL
MEMBRANE
SURFACE
CONTAINS coat of GLYCOPROTEIN
THAT
REPEL normal endothelium
ADHERE injured vascular wall
CHARACTERISTICS OF
PLATELETS
CELL
MEMBRANE
SURFACE
CONTAINS PHOSPHOLIPIDS ,
that
ACTIVATES
multiple stages of blood clotting.
HEMOSTASIS
prevention of blood loss
4 main steps of hemostais
①Vascular contriction
②Platelet plug formation
③Blood clot formation
④Fibrous tissues grows into blood clot
Vascular contriction
• when blood vessel ruptures, trauma causes smooth muscle of vessel
wall to contract.
• contraction of vessel reduces the blood flow.
• Contraction results due to
• local myogenic spasm
• local autacoid factors
• nervous reflexes
Platelet plug formation
• PLATELETS then changes their physical characteristics on exposure to
damage vessel
①they swells
②they develops irridating pseudopodia
③contraction of contractile proteins , that releases the granules
containg activating factor for clotting.
④they become sticky , so they attaches to collagen and Vol
willebrand factor.
⑤they secretes ADP
⑥synthesis Thromboxane A2
Platelet plug formation
• ADP and Thromboxane a2
• act on nearby platelets and activates them,
• additional activated platelets stick over those originally activated platelets.
• At the site of puncture,
• more and more platelet attaches to form platelet plug.
• then fibrin thread form and attaches platelets more tightly.
Blood clot formation
• ACTIVATOR SUBSTANCES are released from,
• traumatized vessel wall
• platelets
• blood proteins
• Activator substances, adhere to the traumatized vessel then initiate
clotting process.
Fibrous organization or Dissolution of clot
• once blood clot form , it can
invaded by fibroblasts
usually when clot is formed
in a small hole,
then connective tissue
fromation occurs.
dissolve
when clot are formed at
those places where it was
not needed
BLOOD COAGULATION
Basic theory
• BODY have procogulants and anticoagulants.
• normally anticoagulant are more, so blood flows freely in vessels
without clotting.
• in INJURED VESSEL , procoagulants become more , so clot formation
happens.
GENERAL MECHANISM
• Formation of PROTHROMBIN ACTIVATOR in response to injured vessel
wall.
prothrombin thrombin
PROTHROMBIN ACTIVATOR
fibrinogen fibrin fibres
THROMBIN ( Ca2+)
APPLIED
• PROTHROMBIN CONCENTRATION - 15mg/dl.
• Formed in liver by using VITAMIN K
• PROTHROMBIN CONCENTRATION DECREASES and lead to
bleeding tendencies :-
• deficiency of VITAMIN K
• liver diseases
Conversion of fibrinogen to fibrin
• Form in liver.
• Plasma concentration : 100 to 700 mg/dl
• normally it doesn't leaks to interstitial fluid.
• THROMBIN act on FIBRINOGEN and convert it to FIBRIN
MONOMERS,
• Fibrin monomers polymerize and form fibrin polymer.
• FIBRIN POLYMER constitute the RETICULUM of blood clot.
Conversion of fibrinogen to fibrin
initially fibrin monomers are loosely bond with weak hydrogen bonds.
FIBRIN - STABILIZING FACTOR activated by thrombin.
formation of srong covalent bond btween fibrin monomers and cross linking
between fibres,
this give tremendously 3 dimensional strength to fibrin meshwork.
COMPOSITION OF CLOT
FIBRIN MESHWORK,
entrapping ,
 blood cells
 platelets
 plasma
fibrin fibres adhere to damage vessels and stop blood loss.
CLOT RETRACTION
-AND EXPRESSION OF SERUM.
clot begins to contracts
expresses most of the
fluid with in 20 to 60
minutes known as SERUM
With in few
minutes of clot
formation,
CLOT RETRACTION
-AND EXPRESSION OF SERUM.
PLATELETS
ARE
NECESSARY,
they bonds different
fibres together
release procogulants
like fibrin stabilizing
factor
platelets contributes to clot
retraction by activating
CONTRACTILE PROTEINS
 thrombosthenin
 actin
 myosin
ALSO ACTIVATED BY
THROMBIN WITH Ca2+
CLOT RETRACTION
-AND EXPRESSION OF SERUM.
CONTRACTION
OF CONTRACTILE
PROTEINS
Strong contraction of platelets
spicules attached to fibrins
that compresses fibrin
meshwork into small mass
CLOT RETRACTS
edges of broken vessel come
together leading to hemostatis
1
2
3
4
POSITIVE FEEDBACK OF CLOT FORMATION
Thrombin have proteolytic effect on fibrinogen as well as other
clotting factor like:
 thrombin act on PROTHROMBIN
 thrombin act on FACTORS RESPONSIBLE FOR FORMATION OF
PROTHROMBIN ACTIVATOR
when critical
amount of clot
formed
it causes more and more
blood clot to form by
formation of more and
more thrombin.
continues untill the
blood leakage
ceases
INITIATION OF COAGULATION
INITIATED BY
TWO PATHWAYS
EXTRINSIC PATHWAY
INTINSIC PATHWAY
FORMATION OF
PROTHROMBIN
ACTIVATOR
 trauma to vascular wall
 trauma to blood
 exposure of blood to
damaged endothelial
cell or to collagen
EXTRINSIC PATHWAY FOR INITIATING
CLOTTING
TRAUMA TO VASCULAR WALL
tissue factor/ tissue thromboplastin
VII
VIIa
X
Xa
Ca++
V
Ca++
prothrombin
activator
prothrombin
thrombin
activates
platelet
phospholipids
ENTRINSIC PATHWAY FOR INITIATION OF
CLOTTING
BLOOD TARUMA OR CONTACT WITH COLLAGEN
XII XIIa
HMW kininogen, prekalikrein
XI XIa
Ca++
IX IXa
IXa
IX
VIIIa
Ca++
TISSUE PHOSPHOLIPDS
(released from platelets on
exposure to trauma)
VIII
X Xa
prothrombin activator
V
Va
Ca++
prothrombin thrombin
Ca++
thrombin
thrombin
PREVENTION OF BLOOD CLOTTING IN
NORMAL VASCULAR SYSTEM.
Endothelial surface factors
smoothness of endotethelial surface
layer of glycocalyx on the endothelium
Protein bound with endothelial membrane , Thrombomodulin
THROMBOMODULIN
binds thrombin
Thrombomodulin-
thrombin complex
activates plasma
protein PROTIEN C
PROTEIN C inactivates factor Va and VIIIa
PREVENTION OF BLOOD CLOTTING IN
NORMAL VASCULAR SYSTEM.
• Antithrombin action of Fibrin and antithrombin III
During formation of clot,
90% of fibrin is absorbed
by fibrin fibres
it prevent spread of
thrombin and formation
of clot
remaining 10%
thrombin combines
with Antithrombin III
which further block
the effects of thrombin
• HEPARIN
• COMBINES with Antithrombin III , increases the effectiveness by 100
to 1000 times.
PREVENTION OF BLOOD CLOTTING
IN NORMAL VASCULAR SYSTEM.
HEPARIN - ANTITHROMBIN III COMPLEX
remove several activated coagulation factors,
like XII,XI,X,IX
PREVENTION OF BLOOD CLOTTING
IN NORMAL VASCULAR SYSTEM.
Basophilic Mast cell
HEPARIN
produce largest quantities of HEPARIN
they are abundent near capillaries of lungs and liver
that prevent clotting in small capillaries allowing free flow of blood
• PLASMIN causes lysis of blood clots,
• Plasma proteins , contains euglobin called plasminogen , when
activated form plasmin
PREVENTION OF BLOOD CLOTTING
IN NORMAL VASCULAR SYSTEM.
PLASMIN DIGESTS
FIBRIN FIBRES
FIBRINOGEN
FACTOR V, VIII,XII
PROTHROMBIN
• Activation of plasminogen to form plasmin then lysis of clots.
PREVENTION OF BLOOD CLOTTING
IN NORMAL VASCULAR SYSTEM.
during clot formation,
plasminogen is
entrapped in clot.
injured tissue very slowly release
TISSUE-PLASMINOGEN ACTIVATOR
(t-PA)
few days later when clot stops bleeding,
t-PA converts plasminogen to plasmin
important function of the plasmin system, to remove minute clots,
from millions of tiny peripheral vessels
DISEASES RELATED TO BLOOD COAGULATION
• VITAMIN K DEFICIENCY
• HEMOPHILIA
• THROMBOCYTOPENIA
• DISSEMINATED INTRAVASCULAR COAGULATION
VITAMIN K DEFICIENCY
• Decrease in prothrombin
factor VII
factor IX
factor X
blood clotting factors are produced in liver,
Liver diseases decreases clotting factors and increases bleeding
tendencies
Vit K + Liver carboxylase
VITAMIN K DEFICIENCY
adds carboxyl group to the
glutamic acid residues on
clotting factors:
PROTHROMBIN
Factor VII, IX, X
PROTEIN C
AFTER adding carboxyl group on glutamic
acid residues Vit K oxidized (inactive)
VITAMIN K EPOXIDE REDUCTASE
COMPLEX 1
(VKORc1)
again activates vitamin K ( reduced Vit K)
• Vitamin K synthesis is done by gut flora
• then absorption occurs with absorption of fat.
• in case of GIT disease , Vit K absorption decreases and deficiency can
occur.
• failure of liver to secreate Bile in GIT , decreases absorption of fat, hence
decrease Vit k absorption.
VITAMIN K DEFICIENCY
Vit K injection is administered before major surgeries to prevent
exessive bleeding tendencies
HAEMOPHILIA
• Usually occurs in males
• X linked recessive disorder.
• Deficiency of Factor VIII , Known as CLASSICAL HEMOPHILIA ,
• Also known as HEMOPHILIA A
• Can also occur due to deficiency of Factor IX.
• Patient is normal utill have any trauma.
HAEMOPHILIA
FACTOR VIII
SMALL
COMPONENT
LOST
HAEMOPHILIA A
LARGE
COMPONENT
LOST
VON WILLEBRAND
DISEASE
THROMBOCYTOPENIA • Deficiency of platelets.
Lack of repair of
vascular damages
in small vessel.
Small punctate
hemorrhages
occurs in all body
tissues
Small purplish
blotches appears
on skin
Known as
THROMBOCYTOPENIC
PURPURA
THROMBOCYTOPENIA
BLEEDING usually occurs
when
Platelets < 50,000
If less than 10,000 platelets
,
It would be lethal.
TREATMENT
1. BLOOD
TRANSFUSION
2. SPLENECTOMY
THROMBOEMBOLIC CONDITION
Thrombus
Abnormal clot
that develop in
vessel wall
Sticked to the
vessel wall
Continues
strike by
flowing blood
It break off ,
then known as
embolus.
THROMBOEMBOLIC CONDITION
EMBOLI
(free floating clot in blood)
IF ORIGINATE IN LEFT
SIDE OF HEART
Plug arterioles in brain ,
kidney.
IF ORIGINATE IN RIGHT
SIDE OF HEART
Plug arterioles in lungs causing
pulmonary artries embolism
• Rough endothelial surface of Blood vessel.
• Arteriosclerosis
• Infection
• Trauma
THROMBOEMBOLIC CONDITION- CAUSES
• When blood flow slow, as in small capillaries
t-PA is used for treating intravascular clot in case of stroke ,
coronary artery blockage, etc.
Femoral venous thrombosis leading to
Massive pulmonary emobolism
immobile bed
ridden patient
blood flow is
slow in leg veins
for hours
clot form in
leg vein
that thrombus can be upto iliac vein or
IVC
SOMETIMES , a part of thrombus breaks
in the direction of moving blood.
emobli flows to right side of heart, can
cause blokage of pulmonary artries
leading to "MASSAIVE PULMONARY
EMOLISM"
1
2
3
4
5
6
Massive pulmonary
emobolism
IF both pulmonary artries are
blocked , then immidiate
death can occur.
TREATMENT
t-PA theray

PLATELETS- HEMATOLOGY(PHYSIOLOGY) WPS Office.pptx

  • 1.
  • 2.
    CHARACTERISTICS OF PLATELETS •Platelets are DISC shaped. • Platelets are formed in bone marrow by FRAGMENTATION of MEGAKARYOCYTES. • Normal plasma concentration - 150,000 to 300,000 / microlitre. • Half life - 8-12 days.
  • 3.
    CHARACTERISTICS OF PLATELETS CYTOPLASM CONTAINSACTIN , MYOSIN , THROMBOSTHENIN (contractile proteins) contract platelets
  • 4.
    CHARACTERISTICS OF PLATELETS CYTOPLASM CONTAINSResiduals of GOLGI BODIES AND ENDOPLASMIC RETINACULUM synthesis enzymes and store Ca2+
  • 5.
    CHARACTERISTICS OF PLATELETS CYTOPLASM CONTAINSMITOCHONDRIA AND ENZYMES ATP and ADP production
  • 6.
    CHARACTERISTICS OF PLATELETS CYTOPLASM CONTAINSEnzymes for PROSTAGLANDIN synthesis prostaglandin is local hormone.
  • 7.
  • 8.
    CHARACTERISTICS OF PLATELETS CYTOPLASM CONTAINSGROWTH FACTORS FOR vascular endothelial cells vascular smooth muscles fibroblasts
  • 9.
    CHARACTERISTICS OF PLATELETS CELL MEMBRANE SURFACE CONTAINS coatof GLYCOPROTEIN THAT REPEL normal endothelium ADHERE injured vascular wall
  • 10.
    CHARACTERISTICS OF PLATELETS CELL MEMBRANE SURFACE CONTAINS PHOSPHOLIPIDS, that ACTIVATES multiple stages of blood clotting.
  • 11.
  • 12.
    4 main stepsof hemostais ①Vascular contriction ②Platelet plug formation ③Blood clot formation ④Fibrous tissues grows into blood clot
  • 13.
    Vascular contriction • whenblood vessel ruptures, trauma causes smooth muscle of vessel wall to contract. • contraction of vessel reduces the blood flow. • Contraction results due to • local myogenic spasm • local autacoid factors • nervous reflexes
  • 14.
    Platelet plug formation •PLATELETS then changes their physical characteristics on exposure to damage vessel ①they swells ②they develops irridating pseudopodia ③contraction of contractile proteins , that releases the granules containg activating factor for clotting. ④they become sticky , so they attaches to collagen and Vol willebrand factor. ⑤they secretes ADP ⑥synthesis Thromboxane A2
  • 15.
    Platelet plug formation •ADP and Thromboxane a2 • act on nearby platelets and activates them, • additional activated platelets stick over those originally activated platelets. • At the site of puncture, • more and more platelet attaches to form platelet plug. • then fibrin thread form and attaches platelets more tightly.
  • 16.
    Blood clot formation •ACTIVATOR SUBSTANCES are released from, • traumatized vessel wall • platelets • blood proteins • Activator substances, adhere to the traumatized vessel then initiate clotting process.
  • 17.
    Fibrous organization orDissolution of clot • once blood clot form , it can invaded by fibroblasts usually when clot is formed in a small hole, then connective tissue fromation occurs. dissolve when clot are formed at those places where it was not needed
  • 18.
  • 19.
    Basic theory • BODYhave procogulants and anticoagulants. • normally anticoagulant are more, so blood flows freely in vessels without clotting. • in INJURED VESSEL , procoagulants become more , so clot formation happens.
  • 20.
    GENERAL MECHANISM • Formationof PROTHROMBIN ACTIVATOR in response to injured vessel wall. prothrombin thrombin PROTHROMBIN ACTIVATOR fibrinogen fibrin fibres THROMBIN ( Ca2+)
  • 21.
    APPLIED • PROTHROMBIN CONCENTRATION- 15mg/dl. • Formed in liver by using VITAMIN K • PROTHROMBIN CONCENTRATION DECREASES and lead to bleeding tendencies :- • deficiency of VITAMIN K • liver diseases
  • 22.
    Conversion of fibrinogento fibrin • Form in liver. • Plasma concentration : 100 to 700 mg/dl • normally it doesn't leaks to interstitial fluid. • THROMBIN act on FIBRINOGEN and convert it to FIBRIN MONOMERS, • Fibrin monomers polymerize and form fibrin polymer. • FIBRIN POLYMER constitute the RETICULUM of blood clot.
  • 23.
    Conversion of fibrinogento fibrin initially fibrin monomers are loosely bond with weak hydrogen bonds. FIBRIN - STABILIZING FACTOR activated by thrombin. formation of srong covalent bond btween fibrin monomers and cross linking between fibres, this give tremendously 3 dimensional strength to fibrin meshwork.
  • 24.
    COMPOSITION OF CLOT FIBRINMESHWORK, entrapping ,  blood cells  platelets  plasma fibrin fibres adhere to damage vessels and stop blood loss.
  • 25.
    CLOT RETRACTION -AND EXPRESSIONOF SERUM. clot begins to contracts expresses most of the fluid with in 20 to 60 minutes known as SERUM With in few minutes of clot formation,
  • 26.
    CLOT RETRACTION -AND EXPRESSIONOF SERUM. PLATELETS ARE NECESSARY, they bonds different fibres together release procogulants like fibrin stabilizing factor platelets contributes to clot retraction by activating CONTRACTILE PROTEINS  thrombosthenin  actin  myosin ALSO ACTIVATED BY THROMBIN WITH Ca2+
  • 27.
    CLOT RETRACTION -AND EXPRESSIONOF SERUM. CONTRACTION OF CONTRACTILE PROTEINS Strong contraction of platelets spicules attached to fibrins that compresses fibrin meshwork into small mass CLOT RETRACTS edges of broken vessel come together leading to hemostatis 1 2 3 4
  • 28.
    POSITIVE FEEDBACK OFCLOT FORMATION Thrombin have proteolytic effect on fibrinogen as well as other clotting factor like:  thrombin act on PROTHROMBIN  thrombin act on FACTORS RESPONSIBLE FOR FORMATION OF PROTHROMBIN ACTIVATOR when critical amount of clot formed it causes more and more blood clot to form by formation of more and more thrombin. continues untill the blood leakage ceases
  • 29.
    INITIATION OF COAGULATION INITIATEDBY TWO PATHWAYS EXTRINSIC PATHWAY INTINSIC PATHWAY FORMATION OF PROTHROMBIN ACTIVATOR  trauma to vascular wall  trauma to blood  exposure of blood to damaged endothelial cell or to collagen
  • 30.
    EXTRINSIC PATHWAY FORINITIATING CLOTTING TRAUMA TO VASCULAR WALL tissue factor/ tissue thromboplastin VII VIIa X Xa Ca++ V Ca++ prothrombin activator prothrombin thrombin activates platelet phospholipids
  • 31.
    ENTRINSIC PATHWAY FORINITIATION OF CLOTTING BLOOD TARUMA OR CONTACT WITH COLLAGEN XII XIIa HMW kininogen, prekalikrein XI XIa Ca++ IX IXa
  • 32.
    IXa IX VIIIa Ca++ TISSUE PHOSPHOLIPDS (released fromplatelets on exposure to trauma) VIII X Xa prothrombin activator V Va Ca++ prothrombin thrombin Ca++ thrombin thrombin
  • 33.
    PREVENTION OF BLOODCLOTTING IN NORMAL VASCULAR SYSTEM. Endothelial surface factors smoothness of endotethelial surface layer of glycocalyx on the endothelium Protein bound with endothelial membrane , Thrombomodulin THROMBOMODULIN binds thrombin Thrombomodulin- thrombin complex activates plasma protein PROTIEN C PROTEIN C inactivates factor Va and VIIIa
  • 34.
    PREVENTION OF BLOODCLOTTING IN NORMAL VASCULAR SYSTEM. • Antithrombin action of Fibrin and antithrombin III During formation of clot, 90% of fibrin is absorbed by fibrin fibres it prevent spread of thrombin and formation of clot remaining 10% thrombin combines with Antithrombin III which further block the effects of thrombin
  • 35.
    • HEPARIN • COMBINESwith Antithrombin III , increases the effectiveness by 100 to 1000 times. PREVENTION OF BLOOD CLOTTING IN NORMAL VASCULAR SYSTEM. HEPARIN - ANTITHROMBIN III COMPLEX remove several activated coagulation factors, like XII,XI,X,IX
  • 36.
    PREVENTION OF BLOODCLOTTING IN NORMAL VASCULAR SYSTEM. Basophilic Mast cell HEPARIN produce largest quantities of HEPARIN they are abundent near capillaries of lungs and liver that prevent clotting in small capillaries allowing free flow of blood
  • 37.
    • PLASMIN causeslysis of blood clots, • Plasma proteins , contains euglobin called plasminogen , when activated form plasmin PREVENTION OF BLOOD CLOTTING IN NORMAL VASCULAR SYSTEM. PLASMIN DIGESTS FIBRIN FIBRES FIBRINOGEN FACTOR V, VIII,XII PROTHROMBIN
  • 38.
    • Activation ofplasminogen to form plasmin then lysis of clots. PREVENTION OF BLOOD CLOTTING IN NORMAL VASCULAR SYSTEM. during clot formation, plasminogen is entrapped in clot. injured tissue very slowly release TISSUE-PLASMINOGEN ACTIVATOR (t-PA) few days later when clot stops bleeding, t-PA converts plasminogen to plasmin important function of the plasmin system, to remove minute clots, from millions of tiny peripheral vessels
  • 39.
    DISEASES RELATED TOBLOOD COAGULATION • VITAMIN K DEFICIENCY • HEMOPHILIA • THROMBOCYTOPENIA • DISSEMINATED INTRAVASCULAR COAGULATION
  • 40.
    VITAMIN K DEFICIENCY •Decrease in prothrombin factor VII factor IX factor X blood clotting factors are produced in liver, Liver diseases decreases clotting factors and increases bleeding tendencies
  • 41.
    Vit K +Liver carboxylase VITAMIN K DEFICIENCY adds carboxyl group to the glutamic acid residues on clotting factors: PROTHROMBIN Factor VII, IX, X PROTEIN C AFTER adding carboxyl group on glutamic acid residues Vit K oxidized (inactive) VITAMIN K EPOXIDE REDUCTASE COMPLEX 1 (VKORc1) again activates vitamin K ( reduced Vit K)
  • 42.
    • Vitamin Ksynthesis is done by gut flora • then absorption occurs with absorption of fat. • in case of GIT disease , Vit K absorption decreases and deficiency can occur. • failure of liver to secreate Bile in GIT , decreases absorption of fat, hence decrease Vit k absorption. VITAMIN K DEFICIENCY Vit K injection is administered before major surgeries to prevent exessive bleeding tendencies
  • 43.
    HAEMOPHILIA • Usually occursin males • X linked recessive disorder. • Deficiency of Factor VIII , Known as CLASSICAL HEMOPHILIA , • Also known as HEMOPHILIA A • Can also occur due to deficiency of Factor IX. • Patient is normal utill have any trauma.
  • 44.
  • 45.
    THROMBOCYTOPENIA • Deficiencyof platelets. Lack of repair of vascular damages in small vessel. Small punctate hemorrhages occurs in all body tissues Small purplish blotches appears on skin Known as THROMBOCYTOPENIC PURPURA
  • 46.
    THROMBOCYTOPENIA BLEEDING usually occurs when Platelets< 50,000 If less than 10,000 platelets , It would be lethal. TREATMENT 1. BLOOD TRANSFUSION 2. SPLENECTOMY
  • 47.
    THROMBOEMBOLIC CONDITION Thrombus Abnormal clot thatdevelop in vessel wall Sticked to the vessel wall Continues strike by flowing blood It break off , then known as embolus.
  • 48.
    THROMBOEMBOLIC CONDITION EMBOLI (free floatingclot in blood) IF ORIGINATE IN LEFT SIDE OF HEART Plug arterioles in brain , kidney. IF ORIGINATE IN RIGHT SIDE OF HEART Plug arterioles in lungs causing pulmonary artries embolism
  • 49.
    • Rough endothelialsurface of Blood vessel. • Arteriosclerosis • Infection • Trauma THROMBOEMBOLIC CONDITION- CAUSES • When blood flow slow, as in small capillaries t-PA is used for treating intravascular clot in case of stroke , coronary artery blockage, etc.
  • 50.
    Femoral venous thrombosisleading to Massive pulmonary emobolism immobile bed ridden patient blood flow is slow in leg veins for hours clot form in leg vein that thrombus can be upto iliac vein or IVC SOMETIMES , a part of thrombus breaks in the direction of moving blood. emobli flows to right side of heart, can cause blokage of pulmonary artries leading to "MASSAIVE PULMONARY EMOLISM" 1 2 3 4 5 6
  • 51.
    Massive pulmonary emobolism IF bothpulmonary artries are blocked , then immidiate death can occur. TREATMENT t-PA theray